Hemogenyx Pharmaceuticals

HEMO · Main Market · Health Care · mcap £48m · 735.0p

Beta Briefing, track record and bull & bear case are not ready for Hemogenyx Pharmaceuticals yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 34 companies are already wired into a briefing: browse them.

David John Smith 8 Dec – 24 Feb · 3 notices

5.2% → 10.3%

share price at the notices 600.0–1140.0p · now 735.0p 8 Dec 2025 12 Jan 2026 24 Feb 2026

Directors

No open-market share purchases by directors in 12 months.

Company filings. Not investment advice.